© 2018 AIBIOS Co., Ltd.  All rights reserved.

PIPELINE

We actively work with academia and biotechnology companies to optimize the discovery of therapies for the wide range of diseases linked to human immune system.  We are investigating the anti-inflammatory activities of the synthesized compounds using next generation quantum computing platform.  AIBIOS is working on three active programs to resolve unmet medical needs.

Pre-clinical Programs

AIB-301

・Inflammatory Bowel Disease (IBD) - Crohn's Disease (CD)

AIB-401

・ Dementia – Alzheimer’s Disease (AD)

AIB-501

・ Emphysema/COPD

Discovery/Optimization studies

・Rheumatoid Arthritis

 

・Neurodegeneration diseases

・Diabetic nephropathy

・Age-related macular degeneration (AMD)